MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Immunology

Background:

• Atherosclerosis is a cardiovascular disease driven by inflammation.
• MicroRNAs regulate inflammatory responses in macrophages, but their specific roles in atherosclerosis are unclear.
• Macrophage-derived foam cell formation is a key process in atherogenesis.

Purpose of the Study:

• To investigate the role of microRNA-19a (miR-19a) in macrophage-derived foam cell formation during atherosclerosis.
• To identify miR-19a's molecular targets and mechanisms in the context of cardiovascular disease.
• To evaluate the therapeutic potential of inhibiting miR-19a in an animal model of atherosclerosis.

Main Methods:

• Microarray analysis of serum and aortic tissue from coronary heart disease patients and healthy controls.
• Identification of miR-19a target genes using molecular assays.
• In vivo studies using apoE-null mice treated with a miR-19a antagonist and fed a high-fat diet.

Main Results:

• miR-19a was significantly enriched in the serum and atherosclerotic aortic tissue of patients with coronary heart disease.
• HMG-Box Transcription Factor 1 (HBP-1) was identified as a direct target of miR-19a.
• Overexpression of miR-19a led to increased macrophage migration inhibiting factor (MIF) expression.
• Inhibition of miR-19a in mice reduced atherosclerotic plaque formation and lipid accumulation.

Conclusions:

• miR-19a promotes atherosclerosis by enhancing macrophage foam cell formation and inflammatory responses.
• HBP-1 acts as a repressor of MIF, and miR-19a-mediated suppression of HBP-1 leads to elevated MIF levels.
• Inhibiting miR-19a represents a promising therapeutic strategy for mitigating atherosclerosis and cardiovascular disease.